title: DBS: a UK (MHRA) regulatory perspective.
authors.affiliation: UK MHRA, Room 12-2, Market Towers, 1 Nine-Elms Lane, London SW8 5NQ, UK. michelle.beharry@mhra.gsi.gov.uk
authors.forename: Michelle
authors.initials: M
authors.lastname: Beharry
mesh_terms: D000818:Animals; D001774:Blood Chemical Analysis / Q000379:methods*; D001800:Blood Specimen Collection / Q000379:methods*; D003890:Desiccation; D064420:Drug-Related Side Effects and Adverse Reactions; D006077:Government Agencies / Q000331:legislation & jurisprudence*; D033161:Government Regulation; D006801:Humans; D004364:Pharmaceutical Preparations / Q000097:blood*; D010599:Pharmacokinetics; D014116:Toxicology; D006113:United Kingdom
chemical_list: D004364:Pharmaceutical Preparations